Answer
May 19, 2026 - 11:22 AM
Rytary is an extended-release formulation of carbidopa-levodopa, designed to provide more stable levodopa levels and reduce "off" time compared to immediate-release carbidopa-levodopa. Some patients may experience smoother symptom control and fewer motor fluctuations with Rytary, but individual responses vary. Ultimately, whether Rytary is "better" depends on each patient's specific needs and response to treatment.
